Dupilumab 治疗 95 例特应性皮炎患者的有效性:日常实践数据
L.E.M. Wijs, DirkJan Hijnen, Louise A. A. Gerbens(Amsterdam UMC Location University of Amsterdam), A.C.M. Kunkeler(Erasmus MC), Phyllis I. Spuls, N.S. Erler, Loes M. Hollestein(Erasmus MC Cancer Institute), Tamar Nijsten(Erasmus MC), M.A. Middelkamp‐Hup(Amsterdam University Medical Centers), Angela L. Bosma(Amsterdam University Medical Centers)
Cited by 0
Related Papers
Definition of treatment goals for moderate to severe psoriasis: a European consensus
|Archives of Dermatological Research|2010|892
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
|Journal of Clinical Oncology|2015|619
European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy
|Journal of the European Academy of Dermatology and Venereology|2022|419
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
|Journal of Investigative Dermatology|2016|377
Absence of T-regulatory cell expression and function in atopic dermatitis skin
|Journal of Allergy and Clinical Immunology|2005|272